Compensation award — excluded from discretionary-purchase analysis.
Traded Jun 8, 2026 · Filed Jun 11, 2026
Doximity's Interim PAO sold $50K of Doximity shares. It was planned long ago, so it says very little.
Written from the filing's own figures. OQRO describes what was reported and never tells you what to buy or sell
open market sale
Code S — open-market or private sale
~$49,882
Shares × reported transaction price
26 days after results of May 13, 2026, 59 days before results of Aug 6, 2026
Results dates are the company's own 8-K (Item 2.02). Many companies only let insiders trade in a window after results
Footnote references a pre-arranged trading plan (Rule 10b5-1)
Only flagged when a footnote says so; never inferred
| After | Stock | S&P 500 | Difference |
|---|---|---|---|
| 7 days | +2.2% | +1.2% | +1.0% |
| 30 days | +11.3% | +1.6% | +9.8% |
| 90 days | +20.8% | +3.3% | +17.5% |
Past results only. Not a forecast.
Compensation award — excluded from discretionary-purchase analysis.
Derivative exercise or conversion — not an open-market buy.
Derivative exercise or conversion — not an open-market buy.